Cognitive-Behavioral Therapy and Escitalopram for Generalized Anxiety Disorder(GAD)

Clinical trial NCT00219349 · COMPLETED

Trial details

NCT number: NCT00219349
Sponsor: New York State Psychiatric Institute
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Generalized Anxiety Disorder

Start date: 2005-01-01
Primary completion: 2008-07-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.